These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34315420)

  • 1. A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer.
    Turkistani S; Sugita BM; Fadda P; Marchi R; Afsari A; Naab T; Apprey V; Copeland RL; Campbell MC; Cavalli LR; Kanaan Y
    BMC Cancer; 2021 Jul; 21(1):861. PubMed ID: 34315420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
    Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
    Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
    Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes.
    Liu Y; Cai Q; Bao PP; Su Y; Cai H; Wu J; Ye F; Guo X; Zheng W; Zheng Y; Shu XO
    Breast Cancer Res Treat; 2015 Jul; 152(1):183-191. PubMed ID: 26062749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
    Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
    PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.
    Sugita B; Gill M; Mahajan A; Duttargi A; Kirolikar S; Almeida R; Regis K; Oluwasanmi OL; Marchi F; Marian C; Makambi K; Kallakury B; Sheahan L; Cavalli IJ; Ribeiro EM; Madhavan S; Boca S; Gusev Y; Cavalli LR
    Oncotarget; 2016 Nov; 7(48):79274-79291. PubMed ID: 27813494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis.
    Yu J; Shen W; Xu J; Gong B; Gao B; Zhu J
    Technol Cancer Res Treat; 2020; 19():1533033820950827. PubMed ID: 32938310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis.
    Qattan A; Al-Tweigeri T; Alkhayal W; Suleman K; Tulbah A; Amer S
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A panel of eight microRNAs is a good predictive parameter for triple-negative breast cancer relapse.
    Hong HC; Chuang CH; Huang WC; Weng SL; Chen CH; Chang KH; Liao KW; Huang HD
    Theranostics; 2020; 10(19):8771-8789. PubMed ID: 32754277
    [No Abstract]   [Full Text] [Related]  

  • 10. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
    Wang DY; Gendoo DMA; Ben-David Y; Woodgett JR; Zacksenhaus E
    Breast Cancer Res; 2019 Jan; 21(1):18. PubMed ID: 30704524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers.
    Gasparini P; Cascione L; Fassan M; Lovat F; Guler G; Balci S; Irkkan C; Morrison C; Croce CM; Shapiro CL; Huebner K
    Oncotarget; 2014 Mar; 5(5):1174-84. PubMed ID: 24632568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening protective miRNAs and constructing novel lncRNAs/miRNAs/mRNAs networks and prognostic models for triple-negative breast cancer.
    Zhao Y; Song Y; Zhang Y; Ji M; Hou P; Sui F
    Mol Cell Probes; 2023 Dec; 72():101940. PubMed ID: 37871689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-518a-3p Suppresses Triple-Negative Breast Cancer Invasion and Migration Through Regulation of TMEM2.
    Gan L; Yang H; Xiong Z; Yang Z; Wang T; Lyu G
    Technol Cancer Res Treat; 2020; 19():1533033820977523. PubMed ID: 33251982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated miRNA Expression in Triple-Negative Breast Cancer of Ancestral Genomic-Characterized Latina Patients.
    Almohaywi M; Sugita BM; Centa A; Fonseca AS; Antunes VC; Fadda P; Mannion CM; Abijo T; Goldberg SL; Campbell MC; Copeland RL; Kanaan Y; Cavalli LR
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
    Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L
    Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of microRNAs in triple-negative breast cancer.
    Paszek S; Gabło N; Barnaś E; Szybka M; Morawiec J; Kołacińska A; Zawlik I
    Ginekol Pol; 2017; 88(10):530-536. PubMed ID: 29192413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
    Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.
    Koleckova M; Ehrmann J; Bouchal J; Janikova M; Brisudova A; Srovnal J; Staffova K; Svoboda M; Slaby O; Radova L; Vomackova K; Melichar B; Veverkova L; Kolar Z
    Sci Rep; 2021 Mar; 11(1):5145. PubMed ID: 33664322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.